JAZZ vs TMP
Jazz Pharmaceuticals PLC (JAZZ) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the JAZZ and TMP stock pages for the full models.
Not investment advice.